News Tag: Corporate Information

During the month, we continued to strengthen the organization in order to meet growing demand and manage an increasing number of start-ups, installations and customer dialogues. The number of active Dosell units increased during the month by approximately 5 percent compared with the previous month, driven by new implementations and expansions among existing customers.

At the same time, we see clear signs that the market for medication dispensing devices continues to mature rapidly, particularly in Sweden, where the ADDA framework agreement is now creating new opportunities for municipalities and regions to initiate broader rollouts.

Sweden – Increased Activity Following ADDA
Since the ADDA framework agreement came into effect, we have seen a clear increase in interest from municipalities that are now evaluating how Dosell can be implemented on a larger scale. Several municipalities are planning call-offs under the framework agreement, and we are engaged in ongoing dialogues regarding upcoming implementations.

During April, we continued to carry out a large number of demonstrations, start-ups and customer meetings. We also see that several processes are moving faster than before, with some municipalities now progressing from initial dialogue to decision within a significantly shorter timeframe.

We have also demonstrated Dosell to a first major municipality through ADDA and are now awaiting feedback on the next steps in the process.

At the same time, more municipalities are continuing to move from pilot projects to broader deployment. This confirms that medication dispensing devices are increasingly being viewed as a natural part of future medication management and preventive care.

Vitalis – Strong Interest in Medication Dispensing Devices
At the beginning of May, we participated for the first time with our own booth at Vitalis, the largest e-health and welfare technology exhibition in the Nordic region. The event was highly successful, and we held a large number of meetings with municipalities, regions and collaboration partners.

A clear trend from this year’s exhibition was that medication dispensing devices are now a prioritized area for many municipalities and regions. The ADDA framework agreement has contributed to increased visibility for the topic, and several presentations and discussions during the event focused on the benefits of digital medication management and how municipalities are working to strengthen independence and safety for users.

Among other things, results were presented from municipalities already using medication dispensing devices, showing very high levels of perceived safety and independence.

The Netherlands – Continued Focus on Scaling
In the Netherlands, we continue to build for long-term growth. The organization has been strengthened with additional resources to manage more implementations and a higher pace of scaling in the coming quarters.

During April, we continued dialogues with both new and existing care organizations regarding the scaling of Dosell. A particular focus is on integrations and simplified implementation flows, which are key to scaling the solution efficiently in the Dutch market.

Finland and Other Markets
We continue our work in Finland, where we submitted a major tender in April with significant potential. At the same time, dialogues and activities continue together with our partners in Norway, Iceland and Spain.

Across several markets, we see the same overall trend as in Sweden: an increasing focus on digitalization, independence and more efficient medication management within healthcare and social care.

Product, Quality and Scalability
To meet the increasing activity level and prepare for more parallel start-ups, we have strengthened the organization within implementation, support, technology and quality assurance. The purpose is to reduce lead times, improve onboarding and ensure stable operations as Dosell is scaled across more markets.

We also continue to develop our platform and workflows with a focus on scalability, user experience and stability. Among other things, further work has been carried out on our remote care platform and new onboarding flows.

Looking Ahead – From Pipeline to Implementation
After a period focused on tenders, partnerships and market development, we are now entering a phase where implementation and scaling are becoming increasingly important. In the coming months, the work will primarily focus on converting the increased interest into concrete start-ups, more active units and scalable implementations.

Our priorities going forward are to:

• Carry out start-ups and implementations in new municipalities
• Continue the work with call-offs through ADDA
• Drive scaling in the Netherlands
• Strengthen the organization in line with growth
• Continue developing our international partner dialogues

We remain committed to working long term and purposefully to make Dosell a natural part of the future of medication management.

Thank you for following our journey.

The award relates to tender area Group B, simple medication dispensing device, where Dosell is offered as a solution for medication management within municipal healthcare and social care. Delivery and implementation are carried out in collaboration with Atea Sverige AB.

The contract entered into force on April 1, 2026 and is valid for two years, with the option to extend for an additional one plus one years. Deliveries will be carried out gradually during the contract period based on call-offs from the municipalities.

The estimated total volume in the procurement amounts to approximately 500 units, which at full deployment corresponds to an annual recurring revenue of approximately SEK 3.7 million for iZafe Group.

“We are pleased to have the opportunity, together with Atea Sweden, to deliver our solution to Västervik and the collaborating municipalities, several of which are already using it today,” says Anders Segerström, CEO of iZafe Group AB.

Dosell is a connected medication dispensing device that supports correct and safe medication management in the home. The solution is used within municipal operations and is designed to meet requirements for functionality, safety and user-friendliness.

Through this contract, iZafe Group strengthens its presence in the Swedish municipal market within digital medication management.

ISO/IEC 27001 is a globally recognized standard that ensures organizations work in a structured and systematic way to protect information, manage risks, and maintain a high level of security across their operations.

The certification confirms that iZafe has implemented a robust and scalable information security management system, in line with the requirements of customers, partners, and regulatory authorities in the markets where the company operates.

“This is an important milestone for iZafe and a clear validation of the work we have done to build a secure and scalable platform. The certification strengthens our competitiveness in tenders, simplifies dialogues with larger customers and partners, and creates strong conditions for continued international expansion,” says Anders Segerström, CEO of iZafe Group.

As demand for digital healthcare solutions continues to grow, so do the requirements for secure handling of data and systems. With the ISO/IEC 27001 certification, iZafe Group further strengthens its position as a trusted provider in digital medication management and remote care, taking another step forward in its commercial development.

More information about iZafe Group’s work within information security and compliance can be found on the company’s Trust Center: https://compliance.izafegroup.com/

The certification is valid until April 2029 and will be subject to annual audits.

Sweden – ADDA in effect and growing demand
On March 31, the ADDA framework agreement came into effect, enabling municipalities and regions to procure Dosell directly through the national framework. We already have our first contract in place and are in dialogue with several municipalities planning to place orders in the near term.

During March, we received orders from two larger municipalities that have decided to switch from previous solutions to Dosell, corresponding to approximately 150 and 100 units respectively. Deployment will take place gradually throughout Q2.

We have also been awarded a contract in the Jönköping region through a procurement outside of ADDA, opening up new use cases related to more preventive care.

During the month, we conducted 16 demonstrations and initiated implementations in three new municipalities. We continue to see a clear trend where more municipalities move from pilot projects to broader deployment.

Organization – investing to enable scale
Following the directed share issue of approximately SEK 19.8 million, we are actively strengthening the organization across sales, implementation, and support.

This work is crucial for our continued growth, but it also means that a significant amount of time and focus is currently devoted to recruitment, onboarding, and building internal structures. This impacts short-term capacity but is a necessary investment to meet demand and scale the business effectively over time.

Netherlands – investments ahead of scaling
In the Netherlands, we continue to strengthen the foundation for growth. The organization has been reinforced with both a Country Manager and an Account Manager, while we have also invested in a larger warehouse to ensure short delivery times.

We have experienced some production delays related to component supply, as a result of the current global situation with disrupted supply chains and longer lead times for electronic components. This means that the next larger production batch is delayed by approximately 2 to 3 months.

The upcoming production includes important adaptations that will allow us to better meet the specific requirements of the Dutch market. This strengthens our position and enables a broader rollout to more customers going forward.

The current version of Dosell is working well and is already in active use among our customers, both in the Netherlands and in other markets, with strong results. At the same time, some customers in the Netherlands have chosen to wait for the updated version before scaling up, as it is optimized for local conditions. This affects the pace in the short term, while we maintain strong delivery capacity in other markets.

Overall, this creates solid conditions for a clear acceleration in the Netherlands during Q2 and Q3.

Norway – ready for rollout
In Norway, everything is now prepared for the launch in the six municipalities included in the procurement we previously won together with our partner Vakt og Alarm. The focus is now on training and implementation.

Demand for medication dispensing solutions is high, and we have also submitted a bid in an additional procurement during the month.

Increased international interest and visibility
During March, we presented Dosell to an international delegation within elderly care from Belgium, with more than 40 participants. The level of interest was very high and confirms the strong need for the solution beyond our current markets.

We have also secured our own booth at Vitalis in May, the largest eHealth event in the Nordics, where we will meet both existing and new customers. In connection with this, our CEO Anders Segerström will also participate as a speaker and panelist on the future of medication management.

Other
During March, we were granted a European patent within data-driven medication management, strengthening our long-term position and intellectual property value.

At the same time, we continue our work together with partners in Finland, Iceland, and Spain.

Looking ahead – focus on delivery and execution

We are now entering Q2 with a strong pipeline, more contracts in place, and an organization that is being strengthened.

Our focus going forward is to:

• Scale up deliveries linked to ADDA and existing agreements
• Execute new municipal implementations
• Continue strengthening the organization
• Drive expansion in the Netherlands
• Support rollouts in Norway

We are in a phase where much of the work is focused on enabling the next stage of growth, with the effects expected to become more visible during Q2 and onwards.

We continue to work with determination to make Dosell a natural part of the future of medication management.

Thank you for following our journey.

Dosell has been awarded sub-contract B, relating to a basic medication dispensing device, where the company’s solution has been evaluated as meeting high standards in terms of functionality, user-friendliness and quality.

The agreement is a framework agreement enabling successive call-offs from both the region and municipalities. The agreement entered into force on April 1, 2026, and runs for an initial period of two years, with the possibility of extension up to a total of four years. As a framework agreement, no volumes are guaranteed, and demand is realized through ongoing call-offs during the contract period.

“This is a strategically important award for us. The fact that an entire region together with its municipalities chooses to procure within a common structure creates strong conditions for broad and gradual implementation over time. It confirms that Dosell meets the requirements of modern healthcare and strengthens our position as a leading player in the field,” says Anders Segerström, CEO of iZafe Group.

The total estimated value of the procurement amounts to approximately SEK 55 million, with a maximum ceiling value of SEK 82.5 million. No allocation of value between the different sub-contract areas has been specified.

The award strengthens iZafe Group’s presence in the Swedish market and establishes an important platform for continued growth and rollout of Dosell within public healthcare and social care.

The patent covers a system where patient data from sensors is analyzed to identify changes in health status. Based on this information, medication treatment can be adjusted over time, enabling more personalized and proactive care.

Although the patent is not directly linked to Dosell’s current functionality, it aligns with iZafe Group’s strategic direction of combining medical technology, data, and future AI-based analytics.

Through this patent, the company strengthens:

• its technological platform for future solutions
• its intellectual property value
• its position within a growing global healthcare segment

In the long term, the technology enables solutions where treatment can be optimized based on real patient data, contributing to improved patient safety and more efficient healthcare.

“This patent is an important step in our long-term strategy. It clearly demonstrates the direction we are moving in—towards more data-driven, intelligent, and personalized healthcare. At the same time, it strengthens our intellectual property and future potential,” says Anders Segerström, CEO of iZafe Group.

As previously communicated, Dosell was awarded a place in the procurement together with a limited number of suppliers. The procurement represents Sweden’s first national procurement of medication dispensing robots and aims to provide municipalities and regions with a simple and quality assured way to implement digital solutions that enhance patient safety and improve the efficiency of medication management within healthcare and elderly care.

As the framework agreement has now been signed and will enter into force on March 31, municipalities and regions using Adda’s purchasing central will be able to initiate call offs under the agreement.

Interest in medication dispensing robots is increasing as healthcare systems face major challenges related to an ageing population, workforce shortages and the need to strengthen patient safety. Digital solutions such as Dosell can help ensure the right medication at the right time while allowing healthcare staff to use their resources more efficiently.

“The fact that the framework agreement has now been signed means that municipalities across Sweden will have a structured and accessible way to implement Dosell through Adda’s procurement. We see a clear increase in interest in digital solutions for medication management and look forward to contributing to safer and more efficient care together with municipalities and partners,” says Anders Segerström, CEO of iZafe Group.

The framework agreement enables municipalities and regions to conduct call offs during the agreement period in accordance with Adda’s procurement terms.

Over the past few years, we have built a solid foundation with more municipalities, new markets and a growing partner network. With ADDA now in place and a strengthened organization, we are entering the next phase where the focus is on scaling deliveries of Dosell and meeting the increasing demand.

Sweden – ADDA opens the door for broader adoption
The most significant event in February is the award in Sweden’s first national procurement of medication dispensing robots through ADDA. The framework agreement enables municipalities across the country to more easily procure Dosell via ADDA without having to conduct their own full procurement processes.

The standstill period runs until March 10, which means the agreement can be signed on March 11. We see this as an important milestone that creates new opportunities for broader adoption of Dosell in Swedish elderly care.

During the winter, many municipalities have been waiting for this decision before moving forward in their processes. February has therefore been relatively quiet in terms of new agreements, but we see the award decision as crucial for enabling several ongoing dialogues to move forward.

At the same time, some municipalities continue to conduct their own procurements outside ADDA. During February we have worked intensively with several such processes and hope to receive decisions in some of them during March.

Interest from municipalities remains strong. During February we conducted five additional product demonstrations and several tender presentations. We also continue to be contacted directly by municipalities interested in learning more about how Dosell can contribute to safer medication management.

An important milestone during the month is that a municipality previously working with another supplier has been running a pilot with Dosell since November. The outcome has been very positive and the municipality has now placed an order for an additional 40 units, thereby replacing its previous solution.

We have also initiated the onboarding of two new municipalities that will begin their implementations in March. At the same time, we see a clear trend where more municipalities are moving from pilot projects to broader deployment.

Growth capital to accelerate the next phase
During February, a directed share issue of approximately SEK 19.8 million was completed. The capital has been raised to further accelerate the company’s growth.

The new capital will be used, among other things, to strengthen the organization, increase the installation pace of Dosell and meet the growing demand from municipalities and partners. With more markets and an expanding pipeline, the focus is now on ensuring that we have the right resources in place to deliver in line with demand.

The Netherlands – continued scaling
Development in the Netherlands continues steadily and the market shows clear structural growth. During February we held several meetings with healthcare providers on how Dosell can be scaled up following initial implementations.

In the coming months, approximately 30 new departments within existing care providers are expected to begin using Dosell.

We have also completed several integrations, including with the system Bprocare, which simplifies implementation within existing healthcare workflows.

To further strengthen our presence, we have now recruited a Country Manager for the Netherlands. The role will focus on developing both direct sales and partner relationships, while creating a more scalable commercial structure to support continued growth in the market.

Norway – ready for rollout
In Norway, everything is now prepared for the rollout in the six municipalities included in the procurement we previously won together with our partner Vakt og Alarm.

Vakt og Alarm is a committed partner that sees strong potential in Dosell and in how the solution can contribute to more efficient medication management in Norwegian home care. Demand for medication dispensing solutions in Norway is high, and together we see strong opportunities to grow in this market. During February we also submitted a bid in another Norwegian procurement.

Finland, Iceland and Spain
Together with our partners, work also continues in our other markets. In Finland, Iceland and Spain, ongoing activities are underway to develop collaborations, strengthen market presence and create conditions for future implementations.

Although we do not have specific news to report from these markets this month, the work with our partners continues in a positive direction, with a focus on developing partnerships, strengthening market presence and preparing for future implementations.

Looking ahead – a strong position heading into spring
With the ADDA award, new growth capital to strengthen the organization and continued strong demand, we are entering the spring with good visibility.

During March, the focus will be on finalizing the ADDA process, receiving decisions in ongoing procurements, launching implementations with new municipalities in Sweden, continuing the scaling in the Netherlands and supporting our partners in other markets.

We will continue to work purposefully to make Dosell a natural part of the future of medication management.

Thank you for following our journey.

This marks Sweden’s first national procurement of medication dispensing systems and remote care platforms. The framework agreement enables municipalities and regions across Sweden to procure Dosell’s solution for safe, quality-assured and efficient medication management in home care settings without conducting their own procurement processes.

According to ADDA’s procurement documentation, the estimated total annual value of the framework agreement amounts to approximately SEK 200 million. The estimate refers to the aggregated volume across all suppliers included in the framework agreement.

Dosell AB has fulfilled all administrative requirements, qualification criteria and all requirements relating to the procurement scope.

“This national procurement represents an important step toward establishing medication dispensing systems as a natural part of future healthcare and elderly care in Sweden. By consolidating the market within a national framework agreement, municipalities are given improved conditions to scale implementation, which can contribute to enhanced patient safety, reduced medication errors and more efficient use of resources within home care and community healthcare services.

It is positive for the market that multiple suppliers are included and can jointly drive development forward. For iZafe, being part of this first national framework agreement is of significant strategic importance. It provides access to a broad national market and we will now work purposefully to ensure that Dosell becomes the preferred choice for as many municipalities as possible,” says Anders Segerström, CEO of iZafe Group.

The standstill period runs until 10 March 2026. Framework agreements may be signed once the standstill period has expired.